CG Oncology, Inc
Price
FilingsNewest: 10-Q, Quarterly reportAug 6 →InsidersNo open-market buys. 2 insiders sold $2.7M, all 12 sales on a 10b5-1 plan.→HoldersRTW Investments 9.6%Decheng Capital 7.2%BlackRock 7.1%→PeersClosest companies: PYXS, PASG, CABA→
From the filings
Figures
- Revenue
- $6.2Mlast 12 months
- Net income
- −$224.4Mlast 12 months
- Operating cash flow
- −$160.0Mlast 12 months
- Cash and equivalents
- $19.6Mat the last balance sheet
- Total debt
- $3.0Mat the last balance sheet
- Shares outstanding
- 88.3M shareson issue